.png)
CANCER IMMUNOTHERAPY TREATMENT
With the first Indian FDA approved patented Immunotherapy, APCEDEN®, we aim to turn the tables on cancer and fight with our cancer patients.
Today, our versatile research team of scientists and doctors are going deeper into creating unmatched personalised therapeutics to enhance the immune system further enabling it to recognise and fight cancer better.
Frontiers In The Development Of Personalised Therapies
Apac Biotech was built on the belief that our immune system is powerful enough to fight cancer from within and now with Apac’s personalised immunotherapies we plan turn the tables on cancer and fight with the cancer patients.
Our flagship product APCEDEN® was the first Indian FDA approved and patented immunotherapy technology for the treatment of cancer. Today, our versatile research team of scientists and doctors are going deeper into creating unmatched personalised therapeutics to enhance the immune system further.
TECHNOLOGY
Our commitment to improve the quality of life of our cancer patients, drives us in everything we do.
APCEDEN® Personalised Immunotherapy
Dendritic Cell immunotherapy activates the immune system of the cancer patient to generate an immune response against the tumor
KeepMyTumor Tumor Banking
Cancer Patients can bank their tumor us and take advantage of rapidly evolving Cancer treatment and Diagnostic technologies
Meet The Team
Arun Mehra
(MD/CEO)
Dr. Bandana Sharan
(Director-Research)
Chaitanya Kumar
(Asst. Research Director)
